Segeberger Kliniken

Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial (2025) Feistritzer HJ, Jobs A, Zeymer U, Schneider S, Lauten P, Ferenc M, Weferling M, et al. Journal article Position paper of the German Cardiac Society on drug-releasing coronary stents/scaffolds and drug-coated balloon catheters: From the Committee for Clinical Cardiovascular Medicine in cooperation with the Working Group Interventional Cardiology (AGIK) DGK-Positionspapier zu medikamentenfreisetzenden Koronarstents/-scaffolds und medikamentenbeschichteten Ballonkathetern: Aus der Kommission für Klinische Kardiovaskuläre Medizin in Kooperation mit der Arbeitsgruppe Interventionelle Kardiologie (AGIK) (2025) Nef HM, Ahrens I, Dörr O, Gaede L, Gori T, Hofmann FJ, Joner M, et al. Journal article In-hospital Outcomes of Rotational Atherectomy in ST-Elevation Myocardial Infarction: Results From the Multicentre ROTA-STEMI Network (2024) Hemetsberger R, Mankerious N, Muntané-Carol G, Temporal J, Sulimov D, Gaede L, Woitek F, et al. Journal article Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes-A Post-hoc Analysis of the ISAR-REACT 5 Trial (2022) Lahu S, Scalamogna M, Ndrepepa G, Menichelli M, Valina C, Hemetsberger R, Witzenbichler B, et al. Journal article Ticagrelor or Prasugrel in Patients with Acute Coronary Syndrome and High Bleeding Risk (2022) Lahu S, Presch A, Ndrepepa G, Menichelli M, Valina C, Hemetsberger R, Witzenbichler B, et al. Journal article Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trial (2022) Lahu S, Ndrepepa G, Neumann FJ, Menichelli M, Bernlochner I, Richardt G, Wohrle J, et al. Journal article Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes Índice de masa corporal y eficacia y seguridad del ticagrelor frente al prasugrel en pacientes con síndrome coronario agudo (2022) Lahu S, Behnes M, Ndrepepa G, Neumann FJ, Sibbing D, Bernlochner I, Menichelli M, et al. Journal article Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB (TM)): 2-year results from the GABI-R-registry (2022) Pahmeier K, Neusser S, Hamm C, Kastner J, Wohrle J, Zahn R, Achenbach S, et al. Journal article Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy (2022) Hemetsberger R, Richardt G, Lahu S, Valina C, Menichelli M, Abdelghani M, Wohrle J, et al. Journal article No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access - Results From the German Austrian ABSORB Registry (GABI-R). (2022) Wein B, Zaczkiewicz M, Graf M, Zimmermann O, Gori T, Nef HM, Kastner J, et al. Journal article